glp-1 receptor agonist pancreatitis risk meta-analysis Safety of agonists in type 1 diabetes: a systematic review and Dose-dependent pancreatitis risk associated with
Description
Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites
J Manag Care Pharm
These clinical trials aim to show a reduction in insulin resistance and improved glycemic management when GLP-1s are used in addition to insulin
A narrative review of clinical studies
Ornelas C, Caiado J, Lopes A, Pereira Dos Santos MC, Pereira BM
